Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage in Patients With Atrial Fibrillation

NCT02105584 is registered in ClinicalTrials.gov with Occlutech International AB as lead sponsor.

NCT NCT02105584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02105584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage in Patients With Atrial Fibrillation
Lead sponsor
Occlutech International AB
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2014
Completion date
September 30, 2017
Enrollment
78 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation